BerandaEVGN • NASDAQ
add
Evogene Ltd
Tutup sebelumnya
$1,00
Rentang hari
$0,99 - $1,01
Rentang tahun
$0,99 - $8,90
Kapitalisasi pasar
6,45Â jt USD
Volume Rata-Rata
20,72Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,61Â jt | 178,72% |
Biaya operasional | 5,92Â jt | -24,14% |
Laba bersih | 427,00Â rb | 106,47% |
Margin laba bersih | 26,51 | 102,32% |
Penghasilan per saham | 0,06 | 104,62% |
EBITDA | -4,47Â jt | 35,76% |
Tarif pajak efektif | 350,00% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 15,31Â jt | -50,71% |
Total aset | 39,86Â jt | -21,99% |
Total liabilitas | 25,03Â jt | 11,64% |
Total ekuitas | 14,84 jt | — |
Saham yang beredar | 6,51 jt | — |
Harga terhadap nilai buku | -4,52 | — |
Tingkat pengembalian aset | -31,68% | — |
Tingkat pengembalian modal | -83,71% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 427,00Â rb | 106,47% |
Kas dari operasi | -5,21Â jt | 12,12% |
Kas dari investasi | 8,76Â jt | 1.594,54% |
Kas dari pembiayaan | 440,00Â rb | 399,32% |
Perubahan kas bersih | 3,98Â jt | 160,74% |
Arus kas bebas | -9,20Â jt | -148,92% |
Tentang
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Didirikan
2002
Situs
Karyawan
117
